Seneca Foods Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Seneca Foods Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,280	1,262	1,315	1,200	1,336	1,468	1,385	1,509	1,459	1,579
Cost of revenue	1,129	1,150	1,082	1,160	1,194	1,235	1,244	1,405	1,270	1,429
Gross profit	151	112	81	39.5	142	232	142	104	188	150
Selling, general and administrative	73.5	73	70.2	72.5	77	80	76.3	81.1	81.2	75.5
Selling and marketing								38.5	34.2	34
General and administrative								42.6	47	41.5
Operating expenses	1,187	1,217
Operating income	91.7	34.7	14.8	-38.1	70.5	181	64	21.4	107	77.8
Interest expense	8.04	9.67	12.8	15.4	11.8	6.13	5.64	14.3	34	33.2
Interest income				0.03	0.03	0.04	0.06	0.53	0.7	0.97
Other non-operating income			6.7	4.26	7.02	-3.47	9.3	6.76	9.79	9.96
Pre-tax income	83.6	25.6	8.73	-49.3	65.6	160	59.9	13.8	83	54.5
Income tax	27.2	9.75	-1.32	-12.8	14.4	33.9	13.7	4.56	19.7	13.3
Income from continuing operations			10	-36.5	51.2	126	46.2	9.23	63.3	41.2
Net income	56.4	15.9	-8.48	5.75	52.3	126	46.2	9.23	63.3	41.2
EBITDA	113	59.6	46.4	-6.84	101	213	101	62.3	151	123
EPS, basic	3.49	0.99	-0.87	0.59	5.62	13.82	5.28	1.19	8.64	5.95
EPS, diluted	3.46	0.99	-0.87	0.59	5.58	13.72	5.24	1.16	8.56	5.90
Shares, basic (weighted)	0.02	0.02	0.01	9.65	9.26	0.01	0.01	7.8	7.32	6.91
Shares, diluted (weighted)	0.02	0.02	0.01	9.65	9.33	0.01	0.01	7.86	7.39	6.98

Balance sheet

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	8.6	12	15.1	11.5	10.7	59.8	10.9	5.24	4.48	42.7
Receivables	76.8	72.1	66.2	84.1	110	92.2	119	97.1	79.8	96.3
Inventory	609	629	547	502	412	343	404	671	873	604
Other current assets	15.8	3.67	1.86	3.08	7.32	3.15	5.19	2.45	2.7	4.31
Total current assets	716	719	741	603	552	516	551	794	967	756
Property, plant and equipment	189	237	259	239	228	249	268	301	305	325
Lease right-of-use assets					60.7	42.2	34	23.2	19.7	10
Other non-current assets	19.7	20.3	3.49	2.8	26	8.81	1.8	1.36	19.4	2.05
Total assets	945	978	1,029	849	909	909	942	1,213	1,384	1,181
Accounts payable	67.4	72.8	56.8	61	71.2	74.1	87.6	69.2	40.3	43.6
Deferred revenue	62.6	46.1	8.36	4.1	7.76	4.29	7.66	9.96	8.19	11.1
Short-term debt	280	3.5	1.66	0.35	0.5	4.5	4	10	19	96
Total current liabilities	461	178	139	112	150	158	173	156	151	215
Long-term debt	36	329	408	266	217	94.1	110	433	586
Lease liabilities					42.8	27.8	22.5	16.7	13.8	6.92
Other non-current liabilities	11.9	3.78	5.83	4.18	5.34	4.01	4.97	3.64	13.9	15
Total liabilities	552	553	618	431	515	332	363	658	801	548
Total debt	316	333	409	266	218	98.6	114	443	605	370
Paid-in capital	97.4	97.5	98.2	98.3	98.4	98.5	98.6	99.2	100	102
Retained earnings	398	401	404	410	460	586	632	641	705	746
Treasury stock	-65.7	-66.5	-69.6	-75.7	-88.3	-91.2	-129	-169	-200	-211
Other comprehensive income	-28.4	-11.2	-25.1	-18.3	-79.2	-19.1	-26.5	-20.5	-25.4	-7.84
Shareholders' equity	393	425	411	417	394	578	579	555	583	633
Total equity	393	425	411	417	394	578	579	555	583	633
Total liabilities and equity	945	978	1,029	849	909	909	942	1,213	1,384	1,181

Cash flow statement

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	56.4	15.9	-8.48	5.75	52.3	126	46.2	9.23	63.3	41.2
Depreciation and amortization	21.7	24.8	31.5	31.2	30.9	32.4	36.5	40.9	43.5	44.8
Stock-based compensation							0.12	0.08	0.25	0.18
Deferred income tax	0.71	8.86	-5.68	0.91	15.5	16.7	7.13	-3.53	-5.53	2.19
Change in receivables	1.29	4.71	-0.67	-5.33	-33.3	24.3	-27	22.1	17.3	-16.6
Change in inventory	-53.5	-19.5	-25.7	142	90.1	68.5	-103	-399	-224	234
Change in payables	-14	-21.7	-14.9	-31.1	-13.5	-65.9	13.5	-18.4	-29.2	3.25
Cash from operations	39.2	24.3	-13.2	97.1	127	183	30.2	-213	-83	335
Capital expenditures	-9.86	-32.1	-32.7	-37.7	-65.7	-71.4	-53.4	-70.6	-36.6	-37.2
Acquisitions	-38.8		-14.4
Cash from investing	-47.6	-31.7	-45	67	-43.2	2.26	-45.2	-64.9	-47.2	-34.8
Debt issued	356	507	532	504	494	478	399	952
Debt repaid	-333	-491		-664	-543	-597	-383	-622
Share buybacks	-6.25	-2.81	-4.56	-7.96	-12.7	-4.36	-38.8	-41.2	-33	-11.6
Dividends paid	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02
Cash from financing	6.47	10.8	61.3	-168	-84.9	-136	-33.9	279	130	-262
Net change in cash	-2.01	3.39	3.11	-3.62	-0.78	49.1	-48.9	1.35	-0.4	38.5
Free cash flow	29.3	-7.82	-45.9	59.4	61.6	112	-23.2	-283	-120	298
Interest paid	6.82	8.35	13.5	15.4	10.8	5.09	4.48	11.2	33.1	34.3
Income taxes paid	24.1	6.28	-3.08	0.17	0.57	22.7	2.97	9.08	15.1	12.7

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $182.53 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	9.5%	Gross profit / revenue.
Operating margin	4.9%	Operating income / revenue.
EBITDA margin	7.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.5%	Pre-tax income / revenue.
Net margin	2.6%	Net income / revenue.
FCF margin	18.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	21.2%	Cash from operations / revenue.
Effective tax rate	24.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	6.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.2%	Net income / average total assets.
Return on invested capital (ROIC)	5.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	4.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.4%	Capital expenditures / revenue.
D&A / revenue	2.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-20.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	2.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-27.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	6.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	2.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-18.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	6.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	3.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-34.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-3.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-4.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-31.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	4.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	1.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y	123.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	21.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	37.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	8.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-14.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-5.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	826.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-5.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.52x	Current assets / current liabilities.
Quick ratio	0.65x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.20x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.58x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	31.3%	Total debt / total assets.
Liabilities / assets	46.4%	Total liabilities / total assets.
Net debt	$327.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.67x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.34x	Operating income / interest expense.
Working capital	$541.1M	Current assets - current liabilities.
Tangible book value	$633.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.23x	Revenue / average total assets.
Fixed asset turnover	5.01x	Revenue / average property, plant and equipment.
Inventory turnover	1.94x	Cost of revenue / average inventory.
Days inventory	189 days	365 x average inventory / cost of revenue.
Receivables turnover	17.9x	Revenue / average receivables.
Days sales outstanding	20 days	365 x average receivables / revenue.
Days payables	11 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	198 days	Days inventory + days sales outstanding - days payables.
FCF conversion	723.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	11.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.90	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$5.95	Net income per basic share, as reported (split-adjusted).
Revenue per share	$226.23	Revenue / diluted weighted shares.
FCF per share	$42.74	Free cash flow / diluted weighted shares.
Operating cash flow per share	$48.07	Cash from operations / diluted weighted shares.
Book value per share	$90.70	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$90.70	Tangible book value / shares outstanding.
Cash per share	$6.12	(Cash + short-term investments) / shares outstanding.
Payout ratio	0.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	0.0%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	3.9%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.24B	Share price x shares outstanding.
Enterprise value	$1.56B	Market cap + total debt - cash - short-term investments.
P/E	30.0x	Market cap / net income. Only when net income is positive.
P/S	0.78x	Market cap / revenue.
P/B	1.95x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.95x	Market cap / tangible book value, when positive.
P/FCF	4.14x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	3.68x	Market cap / cash from operations, when positive.
EV/Sales	0.99x	Enterprise value / revenue.
EV/EBIT	20.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	12.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	5.24x	Enterprise value / free cash flow, when both are positive.
FCF yield	24.1%	Free cash flow / market cap.
Earnings yield	3.3%	Net income / market cap (the inverse of P/E).
Dividend yield	0.0%	Dividends paid over the period / market cap.
Shareholder yield	0.9%	(Dividends paid + share buybacks) / market cap.
PEG	7.43x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Seneca Foods Corp's revenue in fiscal 2025?

Seneca Foods Corp reported revenue of $1.58B for fiscal 2025, 8.2% higher than the year before.

Was Seneca Foods Corp profitable in fiscal 2025?

Yes. Net income was $41.2M, a net margin of 2.6%.

How much free cash flow did Seneca Foods Corp generate in fiscal 2025?

Cash from operations of $335.5M minus capital expenditures of $37.2M left free cash flow of $298.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Seneca Foods Corp